Related Experiment Video
Updated: May 3, 2026

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
Role of statin in atrial fibrillation-related stroke: an angiographic study for collateral flow
Mi Ji Lee1, Oh Young Bang, Suk Jae Kim
1Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Insights
Statin use before stroke in atrial fibrillation (AF) patients was linked to better collateral blood flow. This suggests statins might benefit AF-related cardioembolic stroke, despite trial exclusions.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- Intensive lipid lowering is standard for atherosclerotic stroke.
- The role of statins in cardioembolic stroke remains unclear.
- This study examines statin association with collateral status in cardioembolic stroke.
Purpose of the Study:
- To investigate the relationship between statin use and pretreatment collateral status in patients with cardioembolic stroke.
- To assess if statin use influences collateral circulation in acute middle cerebral artery infarction due to atrial fibrillation.
Main Methods:
- A collaborative study included 98 patients with acute middle cerebral artery infarction due to atrial fibrillation (AF).
- Cerebral angiography was used to evaluate angiographic collateral grade (ASITN/SIR system).
- The association between collateral grade and statin use/dose at stroke onset was analyzed.
Main Results:
- Statin users (22/98) were older and had more comorbidities than statin-naïve patients (76/98).
- Excellent collaterals (grade 3-4) were more frequent in statin users (50%) versus statin-naïve patients (27.6%; p=0.049).
- Prestroke statin use was independently associated with excellent collaterals (OR, 7.841; p=0.004).
Conclusions:
- Premorbid statin use in AF patients correlates with excellent collateral flow.
- Findings suggest potential benefits of statins in AF-related cardioembolic stroke.
- Further research is warranted given trial exclusions of cardioembolic stroke patients.
Background:
Currently, intensive lipid lowering is recommended in patients with atherosclerotic ischemic stroke or transient ischemic attack. However, the role of statin in cardioembolic stroke is unclear. We investigated the association of statin with pretreatment collateral status in cardioembolic stroke.
Methods:
A collaborative study from two stroke centers in distinct geographic regions included consecutive patients with acute middle cerebral artery (MCA) infarction due to atrial fibrillation (AF) who underwent cerebral angiography. The relationship between pretreatment collateral grade and the use/dose of statin at stroke onset was assessed. The angiographic collateral grade was evaluated according to the ASITN/SIR Collateral Flow Grading System.
Results:
Ninety-eight patients (76 statin-naïve, 22 statin users) were included. Compared with statin-naïve patients, statin users were older and more frequently had hypertension, hyperlipidemia and coronary heart disease. Excellent collaterals (grade 3-4) were more frequently observed in statin users (11 patients, 50%) than in statin-naïve patients (21 patients, 27.6%; p = 0.049). The use of atorvastatin 10 mg equivalent or higher doses of statin was associated with excellent collaterals (p for trend = 0.025). In multiple regression analysis, prestroke statin use was independently associated with excellent collaterals (odds ratio, 7.841; 95% confidence interval, CI, 1.96-31.363; p = 0.004).
Conclusions:
Premorbid use of statin in AF patients is associated with excellent collateral flow. Although most statin trials excluded patients with cardioembolic stroke, our data suggests the possibility that statin may be beneficial in AF-related stroke
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis IV: Nursing Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Angina IV: Management
Acute Coronary Syndrome III: Diagnostic Studies

